Advanced Methodology of Poly(lactic-co-glycolic acid)-based Parenteral Formulations

Learn more about maximizing long-acting parenteral formulations using nanoparticles, microspheres and in-situ forming gels.

Register Free: https://www.pharmtech.com/pt_w/advanced-methodology

Event Overview:

This discussion will review the practical aspects of parenteral formulations containing the biodegradable polymer, poly(lactic-co-glycolic acid), or PLGA. Learn more about degradation and diffusion-based kinetics that are key to designed release profiles of hydrophobic and hydrophilic drugs. Various parenteral formulations such as nanoparticles, microparticles/spheres and in-situ forming gels and their preparations/characterizations will also be discussed.

Key Learning Objectives
Attendees will obtain a greater understanding of:

• The physiochemical properties of poly(lactic-co-glycolic acid).
• Proper selection of an optimal formulation based on desired release kinetics.
• Production and characterization of key parenteral formulations for short- and long-acting release.

Who Should Attend

• Formulation Scientists
• Research and Development (R&D) Scientists
• Directors and Senior Directors of R&D

Speaker

Matthew Owen, Ph.D.
Scientist
Pace® Life Sciences

Matthew Owen graduated with his BS in Chemistry from UC Berkeley, and following completion, he moved on to the UC Davis for his Ph.D. in Physical Chemistry. His research was focused on drug delivery, such as long-acting injectables and dry-powder inhalables. He is the author of numerous scientific publications and patents. He now works at Pace® Life Sciences, where he continues to develop complex formulations and analytical methodology for a wide range of applications.

Register Free: https://www.pharmtech.com/pt_w/advanced-methodology